Oscar Arias-Carrión
Oscar Arias-Carrión
Hospital General Dr. Manuel Gea González
Verified email at ciencias.unam.mx
TitleCited byYear
Dopamine, learning, and reward-seeking behavior.
Ó Arias-Carrión, E Pöppel
Acta Neurobiol Exp, 2007
3172007
Dopaminergic reward system
O Arias-Carrión, M Stamelou, E Murillo-Rodríguez, ...
Int Arch Med 3 (1), 24, 2010
2292010
Effects of Exercise on Anxiety and Depression Disorders: Review of Meta- Analyses and Neurobiological Mechanisms
M Wegner, I Helmich, S Machado, A E Nardi, O Arias-Carrion, H Budde
CNS & Neurological Disorders-Drug Targets 13 (6), 1002-1014, 2014
1952014
Epidemiology of early-onset dementia
RT Vieira, L Caixeta, S Machado, AC Silva, AE Nardi, O Arias-Carrión, ...
Clinical practice and epidemiology in mental health: CP & EMH 9, 88, 2013
1292013
Neurogenesis in the subventricular zone following transcranial magnetic stimulation and nigrostriatal lesions
O Arias‐Carrión, L Verdugo‐Díaz, A Feria‐Velasco, D Millán‐Aldaco, ...
J Neurosci Res 78 (1), 16-28, 2004
1082004
Handbook of cannabis
RG Pertwee
Oxford University Press, USA, 2014
942014
Rational therapeutic approaches to progressive supranuclear palsy
M Stamelou, R de Silva, O Arias-Carrión, E Boura, M Höllerhage, ...
Brain 133 (6), 1578-1590, 2010
942010
EEG-based brain-computer interfaces: an overview of basic concepts and clinical applications in neurorehabilitation
S Machado, F Araújo, F Paes, B Velasques, M Cunha, H Budde, LF Basile, ...
Reviews in the Neurosciences 21 (6), 451-468, 2010
672010
Sleep deprivation and oxidative stress in animal models: a systematic review
G Villafuerte, A Miguel-Puga, E Murillo Rodríguez, S Machado, ...
Oxidative medicine and cellular longevity 2015, 2015
622015
Systemic administration of neuregulin‐1β1 protects dopaminergic neurons in a mouse model of Parkinson’s disease
T Carlsson, FR Schindler, M Höllerhage, C Depboylu, O Arias‐Carrión, ...
Journal of Neurochemistry 117 (6), 1066-1074, 2011
622011
Mechanisms of sleep-wake cycle modulation
E Murillo-Rodríguez, O Arias-Carrión, K Sanguino-Rodríguez, ...
CNS & Neurological Disorders-Drug Targets 8 (4), 245-253, 2009
622009
Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa
A R de Mello Schier, N P de Oliveira Ribeiro, D S Coutinho, S Machado, ...
CNS & Neurological Disorders-Drug Targets 13 (6), 953-960, 2014
602014
The mirror neuron system in post-stroke rehabilitation
D Carvalho, S Teixeira, M Lucas, TF Yuan, F Chaves, C Peressutti, ...
International archives of medicine 6 (1), 1, 2013
602013
Basic mechanisms of rTMS: Implications in Parkinson's disease
O Arias-Carrión
Int Arch Med 1 (1), 2, 2008
582008
Physical activity interventions in schools for improving lifestyle in European countries
G Mura, NBF Rocha, I Helmich, H Budde, S Machado, M Wegner, ...
Clinical practice and epidemiology in mental health: CP & EMH 11 (Suppl 1 M5 …, 2015
552015
Transplantation of hypocretin neurons into the pontine reticular formation
O Arias-Carrión, E Murillo-Rodriguez, M Xu, C Blanco-Centurion, ...
Sleep 27 (8), 1465, 2004
552004
Adult neurogenesis and Parkinson's disease
O Arias-Carrión, N Freundlieb, WH Oertel, GU Hoglinger
CNS & Neurological Disorders-Drug Targets 6 (5), 326-335, 2007
542007
A new dopaminergic nigro-olfactory projection
GU Höglinger, D Alvarez-Fischer, O Arias-Carrión, M Djufri, A Windolph, ...
Acta Neuropathologica 130 (3), 333-348, 2015
532015
The role of positive emotion and contributions of positive psychology in depression treatment: systematic review
V Santos, F Paes, V Pereira, O Arias-Carrión, AC Silva, MG Carta, ...
Clinical practice and epidemiology in mental health: CP & EMH 9, 221, 2013
522013
Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease
C Depboylu, MKH Schäfer, O Arias-Carrión, WH Oertel, E Weihe, ...
Journal of Neuropathology & Experimental Neurology 70 (2), 125-132, 2011
522011
The system can't perform the operation now. Try again later.
Articles 1–20